Skip to main content

Animations

MJFF Publications

2821 - 2830 of 8808 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2010
  • 2021
  • 2013
  • 2023
  • 2020
  • 2024
  • 2020
  • 2019
  • Summary Details
    OPEN
    Title: Characterization of the Basic Membrane Properties of Neurons of the Rat Dorsal Motor Nucleus of the Vagus in Paraquat-Induced Models of Parkinsonism
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2019.08.048
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Heritability and genetic variance of dementia with Lewy bodies
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.04.004
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Dystrophin-associated protein scaffolding in brain requires α-dystrobrevin
    Journal Name: NeuroReport
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/wnr.0b013e32833b0a3b
    Citation Count: 14
  • Summary Details
    OPEN
    Title: The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α‐Synuclein in PDGBA
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28472
    Citation Count: 67
  • Summary Details
    OPEN
    Title: Money without collaboration won't bring cures
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nm0213-127
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Post‐Mortem Studies of Neurturin Gene Therapy for Parkinson's Disease: Two Subjects with 10 Years CERE120 Delivery
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29518
    Citation Count: 15
  • Summary Details
    OPEN
    Title: LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aav0820
    Citation Count: 114
  • Summary Details
    OPEN
    Title: High‐molecular‐weight oligomer tau ( HMWoTau ) species are dramatically increased in Braak‐stage dependent manner in the frontal lobe of human brains, demonstrated by a novel oligomer Tau ELISA with a mouse monoclonal antibody ( APNmAb005 )
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1096/fj.202401704r
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Selective metabotropic glutamate receptor 2 positive allosteric modulation alleviates L-DOPA-induced psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset
    Journal Name: European Journal of Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejphar.2020.172957
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Conversion of Quinazoline Modulators from Inhibitors to Activators of β-Glucocerebrosidase
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.8b01294
    Citation Count: 23
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.